| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 02/20/2003 | WO2002079464A3 Viral vectors |
| 02/20/2003 | WO2002078621A3 Replication-competent recombinant virus and methods of use thereof |
| 02/20/2003 | WO2002029075A9 Multiple inducible gene regulation system |
| 02/20/2003 | US20030036524 Transfecting with a polynucleotide that comprises a prodrug metabolising gene, and a promoter capable of selectively promoting the transcription of the prodrug metabolising gene in said endothelial cell; and delivering said prodrug |
| 02/20/2003 | US20030036088 Separation of viruses in sample; obtain sample containing viruses, incubate with filter, recover and analyze preferential virus from filter |
| 02/20/2003 | US20030035814 Cloning Dna; prevention reproduction; gene therapy |
| 02/20/2003 | US20030035811 Method of inactivating microorganisms |
| 02/20/2003 | US20030035792 Recombinant MVA virus, and the use thereof |
| 02/20/2003 | CA2457349A1 Sub-unit vaccine for infectious pancreatic necrosis virus |
| 02/19/2003 | EP1283895A2 Retroviral vectors comprising an enhanced 3' transcription termination structure |
| 02/19/2003 | EP1283887A1 Chimeric arterivirus-like particles |
| 02/19/2003 | EP1283718A2 Porcine reproductive and respiratory syndrome virus (prrsv) recombinant avipoxvirus vaccine |
| 02/19/2003 | EP0483304B1 Method of inactivation of viral and bacterial blood contaminants |
| 02/19/2003 | CN1398297A Recombinant flaviviruses and methods of use thereof |
| 02/19/2003 | CN1397803A Method for detecting human tumor antigen P 185 Her-2 and its application in diagnosing tumor |
| 02/19/2003 | CN1397642A Recombinant herpesvirus carrying antivascular and antiendothelial cell factors fusion gene |
| 02/19/2003 | CN1397641A Virus reproduced in tumor cell for expressing angiogenesis suppressor factor and its configuring process |
| 02/19/2003 | CN1101852C Recombined Chinese bollworm virus |
| 02/18/2003 | US6521739 Complete genome sequence of a simian immunodeficiency virus from a red-capped mangabey |
| 02/18/2003 | US6521457 Lentivirus-based gene transfer vectors |
| 02/18/2003 | US6521454 Baculoviruses, insecticidal compositions, and methods for control of invertebrates |
| 02/18/2003 | US6521404 Gene expression of library bacteriophage particles with very light domain antibodies and synthetic very heavy antibodies displayed on surface |
| 02/18/2003 | US6521236 Vector vaccine of recombinant feline herpesvirus |
| 02/18/2003 | US6521235 Alphavirus RNA replicon systems |
| 02/18/2003 | CA2100591C Avirulent anti-rabies vaccine |
| 02/13/2003 | WO2003012054A2 Methods and compositions relating to improved lentiviral vector production systems |
| 02/13/2003 | WO2003011893A2 Immunologically significant herpes simplex virus antigens and methods for using same |
| 02/13/2003 | WO2003011209A2 Methods of sensitizing hepatocyte cell cultures to hepatitis infection, beads coated with hbv or hcv polypeptides and methods of using such beads to model viral infection or deliver substances into hepatocytes |
| 02/13/2003 | WO2002062296A3 Methods and compositions useful for stimulating an immune response |
| 02/13/2003 | US20030032613 Novel adenovirus gene therapy vehicle and cell line |
| 02/13/2003 | US20030032176 Helper-free stocks of recombinant adeno-associated virus vectors |
| 02/13/2003 | US20030032036 Expression vector for use in the analysis and classification of antibiotic biosynthetic pathways |
| 02/13/2003 | US20030032008 Immunoassay reagent for use in diagnosis and detection of viral infection |
| 02/13/2003 | US20030032006 A PC12 cell quiescently infected with a human herpes simplex 2 virus (HSV-2); determining the ability of a test reagent to suppress virus reactivation from a quiescently-infected PC12 cells |
| 02/13/2003 | DE10125540C1 Preparing concentrates of viruses that express nitric oxide synthase (NOS), for use in gene therapy of e.g. vascular disease, comprises growing producer cells in the presence of an NOS inhibitor |
| 02/13/2003 | CA2780120A1 Immunologically significant herpes simplex virus antigens and methods for using same |
| 02/12/2003 | EP1282712A2 Synthetic gagpol genes and their uses |
| 02/12/2003 | EP1282692A2 Sentinel virus ii |
| 02/12/2003 | CN1396258A Recopulated strain of rotavirus gene |
| 02/11/2003 | US6518063 Osf2/Cbfa1 nucleic acids and methods of use therefor |
| 02/11/2003 | US6518030 Non-infectious, retrovirus-like particles comprise an assembly of an env gene product, a pol gene product and a gag gene product contain an antigenic marker which is non-retroviral or non-HIV retroviral. In one embodiment, the |
| 02/11/2003 | US6518015 Peptide comprising the sequence CAFRQVC and methods using it |
| 02/11/2003 | US6518014 Hepadnavirus cores |
| 02/11/2003 | US6517843 Recombinant immunogen comprised of an inactivated porcine circovirus-2 |
| 02/11/2003 | US6517842 Marburg virus vaccines |
| 02/11/2003 | CA2058386C Cell free marek's disease virus vaccine |
| 02/06/2003 | WO2003010316A1 Bacteriophage-mediated lysis anthrax bacteria |
| 02/06/2003 | WO2003010306A1 Viral mutants that selectively replicate in targeted human cancer cells |
| 02/06/2003 | WO2003010200A2 Nucleic acid encoding polypeptide involved in cellular entrance of the prrs virus |
| 02/06/2003 | WO2002020722A3 Methods and compositions for in vitro targeting |
| 02/06/2003 | WO2002004596A9 Diagnosing and treating cancer cells using mutant viruses |
| 02/06/2003 | WO2002000883A3 Rescue of canine distemper virus from cdna |
| 02/06/2003 | WO2001004335A8 Human-bovine chimeric respiratory syncytial virus vaccines |
| 02/06/2003 | US20030028922 Chimeric expression promoters originating from commelina yellow mottle virus and cassava vein mosaic virus |
| 02/06/2003 | US20030028920 Antimicrobial polypeptides and their uses |
| 02/06/2003 | US20030028010 Viral nucleotide sequene clone for use as tool in the treatment of viral diseases |
| 02/06/2003 | US20030027338 Mutant adenovirus genome for use as vector in genetic engineering |
| 02/06/2003 | US20030027322 Genration of herpesvirus amplicon particle for use in the treatment of cancer; obtain nucleotide sequences, incubate with expression vectors, ligate recover viral vector |
| 02/06/2003 | US20030027321 Recombinant RSV virus expression systems and vaccines |
| 02/06/2003 | US20030027313 Cloned genes encoding reverse transcriptase lacking RNase H activity |
| 02/06/2003 | US20030027241 For detection of bacteria based on recognition and infection of one or more selected strains of bacteria with bacteriophage genetically modified to cause production of an inducer molecule in the bacterium following phage infection |
| 02/06/2003 | US20030027198 Nucleotide sequences coding polypeptide for use in the treatment of tumors |
| 02/06/2003 | US20030027156 Generation of preferential proein; obtain nucleotide sequences, incubate with cells, transform cells, express nucleotide sequences, recover proteins |
| 02/06/2003 | US20030027130 Nucleotide sequences coding polypeptides for use in the diagnosis and treatment of viral diseases |
| 02/06/2003 | US20030026791 Aids therapy; insertion into cell a virus vector |
| 02/06/2003 | US20030026785 Genetic engineering; activation; administering bacteriophages; side effect reduction |
| 02/05/2003 | EP1281760A1 Porcine circoviruses, vaccines and diagnostic reagents |
| 02/05/2003 | EP1281754A1 Hiv-producing cell line and use thereof |
| 02/05/2003 | EP1280406A1 Vaccines, immunotherapeutics and methods for using the same |
| 02/05/2003 | CN1395491A Polymer blends as biodegradable matrices for preparing biocomposites |
| 02/05/2003 | CN1100876C DNA encoding human paplilloma virus type 18 |
| 02/05/2003 | CN1100872C Process for increasing output of hallworm virus |
| 02/05/2003 | CN1100868C Method of disrupting cultured cells using impinging jet device |
| 02/04/2003 | US6514943 Method and composition for preserving viruses |
| 02/04/2003 | US6514754 Of herpesvirus of turkeys (HVT) inserted in a non-essential region of the vector; may be manipulated to provide vaccines |
| 02/04/2003 | US6514691 An antigenic envelope polypeptide of given amino acid sequence was identified |
| 02/04/2003 | US6514502 Propagation of bovine cononavirus in chinese hamster ovary cells |
| 01/30/2003 | WO2003008599A2 System for producing clonal or complex populations of recombinant adenoviruses, and the application of the same |
| 01/30/2003 | WO2003008586A2 Engineering oncolytic viruses |
| 01/30/2003 | WO2003008567A1 The tumor angiogenesis inhibitory factor-expressed efficiently virus specifically proliferating in tumor cell and uses thereof |
| 01/30/2003 | WO2003008564A2 Methods of polyvalent bacteriophage preparation for the treatment of bacterial infections |
| 01/30/2003 | WO2003008533A2 Method for virus propagation |
| 01/30/2003 | WO2003008455A1 Activity monitor molecules for g-protein trimer |
| 01/30/2003 | WO2003007889A2 Therapeutic agents comprising pro-apoptotic proteins |
| 01/30/2003 | US20030022378 Expression vector for use as transfer tool in genetic engineering |
| 01/30/2003 | US20030022377 Baculovirus-based expression system |
| 01/30/2003 | US20030022376 Viral complex for use in gene therapy |
| 01/30/2003 | US20030022356 Method for producing recombinant virus |
| 01/30/2003 | US20030022355 Vectors and methods for gene transfer |
| 01/30/2003 | US20030022333 Preservation of samples by dehydration; obtain sample, dry, cool and store on shell |
| 01/30/2003 | US20030022228 Amplification of membrane maintenance and suppression of hemolysis of stored blood; obtain blood sample, incubate with support solution, monitor erythrocyte and platelet stability |
| 01/30/2003 | US20030022159 Method for identifying intercellular protein factors |
| 01/30/2003 | US20030022156 Transducing Phages |
| 01/30/2003 | US20030021768 Viral mutants that selectively replicate in targeted human cancer cells |
| 01/30/2003 | US20030021767 Recombinant p53 adenovirus methods and compositions |
| 01/29/2003 | EP1279731A1 Process for the development of binding mini-proteins |
| 01/29/2003 | EP1278878A2 Codon optimisation for expression in retrovirus packaging cells |
| 01/29/2003 | EP1278874A2 Hybrid protein and vector encoding the same for inhibition of angiogenesis |
| 01/29/2003 | EP1278849A2 Thrombopoietin receptor modulating peptide |
| 01/29/2003 | EP1278824A2 Clearance of ras-mediated neoplastic cells from mixed cellular compositions using reovirus |